293 related articles for article (PubMed ID: 19379081)
1. Personalized cancer diagnostics and therapeutics.
Roukos DH
Expert Rev Mol Diagn; 2009 Apr; 9(3):227-9. PubMed ID: 19379081
[No Abstract] [Full Text] [Related]
2. Genomic microarrays in cancer molecular diagnostics: just biomarker discovery tools or future bedside clinical assays?
Ross JS
Expert Rev Mol Diagn; 2005 Nov; 5(6):837-8. PubMed ID: 16255622
[No Abstract] [Full Text] [Related]
3. Biomarker profiling for cancer diagnosis, prognosis and therapeutic management.
Mitra AP; Lin H; Cote RJ; Datar RH
Natl Med J India; 2005; 18(6):304-12. PubMed ID: 16483031
[TBL] [Abstract][Full Text] [Related]
4. Applications of biochips: from diagnostics to personalized medicine.
Jain KK
Curr Opin Drug Discov Devel; 2004 May; 7(3):285-9. PubMed ID: 15216931
[TBL] [Abstract][Full Text] [Related]
5. New molecular assays for cancer diagnosis and targeted therapy.
Lea P; Ling M
Curr Opin Mol Ther; 2008 Jun; 10(3):251-9. PubMed ID: 18535932
[TBL] [Abstract][Full Text] [Related]
6. [Molecular markers having a prognostic or therapeutic value in cancer].
Brousset P
Ann Pathol; 2008 Nov; 28 Spec No 1(1):S69-70. PubMed ID: 18984307
[No Abstract] [Full Text] [Related]
7. Molecular cancer diagnostics.
Marte B; Eccleston A; Nath D
Nature; 2008 Apr; 452(7187):547. PubMed ID: 18385727
[No Abstract] [Full Text] [Related]
8. Personalized medicine for cancer: from molecular signature to therapeutic choice.
Sikora K
Adv Cancer Res; 2007; 96():345-69. PubMed ID: 17161685
[No Abstract] [Full Text] [Related]
9. Moving cancer diagnostics from bench to bedside.
Zhang X; Li L; Wei D; Yap Y; Chen F
Trends Biotechnol; 2007 Apr; 25(4):166-73. PubMed ID: 17316853
[TBL] [Abstract][Full Text] [Related]
10. The role of companion diagnostics in the development and use of mutation-targeted cancer therapies.
Papadopoulos N; Kinzler KW; Vogelstein B
Nat Biotechnol; 2006 Aug; 24(8):985-95. PubMed ID: 16900147
[TBL] [Abstract][Full Text] [Related]
11. Molecular diagnostics: impact upon cancer detection.
Keesee SK
Expert Rev Mol Diagn; 2002 Mar; 2(2):91-2. PubMed ID: 11962339
[No Abstract] [Full Text] [Related]
12. Seize the opportunity: underutilization of fine-needle aspiration biopsy to inform targeted cancer therapy decisions.
Clark DP
Cancer; 2009 Oct; 117(5):289-97. PubMed ID: 19711468
[No Abstract] [Full Text] [Related]
13. Laser Capture Microdissection: a rising tool in genetic profiling of cancer.
Lechpammer M; Sgroi DC
Expert Rev Mol Diagn; 2004 Jul; 4(4):429-30. PubMed ID: 15225089
[No Abstract] [Full Text] [Related]
14. [Diagnosing predisposition to tumor development by genetic typing].
Thomas G
Gastroenterol Clin Biol; 1996; 20(5 Pt 2):B1-4. PubMed ID: 8761114
[No Abstract] [Full Text] [Related]
15. Radiogenomics: creating a link between molecular diagnostics and diagnostic imaging.
Rutman AM; Kuo MD
Eur J Radiol; 2009 May; 70(2):232-41. PubMed ID: 19303233
[TBL] [Abstract][Full Text] [Related]
16. [Molecular medicine--personalized medicine. Principles and state-of-the-art].
Blum HE
Dtsch Med Wochenschr; 2005 Jun; 130(25-26):1568-72. PubMed ID: 15965865
[No Abstract] [Full Text] [Related]
17. Gene expression profiling of sarcomas.
Slavin JL; Thomas D
Pathology; 2006 Apr; 38(2):101-2. PubMed ID: 16581648
[No Abstract] [Full Text] [Related]
18. [Solid tumors. Classification based on molecular biology, prognosis and therapy].
Fenger C; Dutoit SH
Ugeskr Laeger; 2003 Feb; 165(9):905-7. PubMed ID: 12661513
[TBL] [Abstract][Full Text] [Related]
19. Cancer biomarkers: an emerging means of detecting, diagnosing and treating cancer.
Srivastava S
Cancer Biomark; 2005; 1(1):1-2. PubMed ID: 17192027
[No Abstract] [Full Text] [Related]
20. [Genetic testing and gene-based testing for familial tumor].
Sugano K
Nihon Rinsho; 2005 Dec; 63 Suppl 12():191-5. PubMed ID: 16416793
[No Abstract] [Full Text] [Related]
[Next] [New Search]
